These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 6799077
1. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Hansteen V, Møinichen E, Lorentsen E, Andersen A, Strøm O, Søiland K, Dyrbekk D, Refsum AM, Tromsdal A, Knudsen K, Eika C, Bakken J, Smith P, Hoff PI. Br Med J (Clin Res Ed); 1982 Jan 16; 284(6310):155-60. PubMed ID: 6799077 [Abstract] [Full Text] [Related]
2. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients. Hansteen V. Circulation; 1983 Jun 16; 67(6 Pt 2):I57-60. PubMed ID: 6342841 [Abstract] [Full Text] [Related]
3. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression. Shivkumar K, Schultz L, Goldstein S, Gheorghiade M. Am Heart J; 1998 Feb 16; 135(2 Pt 1):261-7. PubMed ID: 9489974 [Abstract] [Full Text] [Related]
8. The Norwegian Multicenter Study of Timolol after Myocardial Infarction. Pedersen TR. Circulation; 1983 Jun 16; 67(6 Pt 2):I49-53. PubMed ID: 6342838 [Abstract] [Full Text] [Related]
9. Chronic beta blockade therapy in patients after myocardial infarction. Pratt CM, Roberts R. Am J Cardiol; 1983 Oct 01; 52(7):661-4. PubMed ID: 6137945 [Abstract] [Full Text] [Related]
11. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results. JAMA; 1983 Nov 25; 250(20):2814-9. PubMed ID: 6358542 [Abstract] [Full Text] [Related]
12. Abrupt withdrawal of beta-blockade therapy in patients with myocardial infarction: effects on infarct size, left ventricular function, and hospital course. Croft CH, Rude RE, Gustafson N, Stone PH, Poole WK, Roberts R, Strauss HW, Raabe DS, Thomas LJ, Jaffe AS. Circulation; 1986 Jun 25; 73(6):1281-90. PubMed ID: 3009050 [Abstract] [Full Text] [Related]
13. Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia. Baber NS, Evans DW, Howitt G, Thomas M, Wilson T, Lewis JA, Dawes PM, Handler K, Tuson R. Br Heart J; 1980 Jul 25; 44(1):96-100. PubMed ID: 7000100 [Abstract] [Full Text] [Related]
14. The Timolol Myocardial Infarction Study: an evaluation of selected variables. Rodda BE. Circulation; 1983 Jun 25; 67(6 Pt 2):I101-6. PubMed ID: 6342836 [Abstract] [Full Text] [Related]
15. The Norwegian propranolol trial in selected patients. Hansteen V. Br J Clin Pharmacol; 1982 Jun 25; 14 Suppl 1(Suppl 1):9S-12S. PubMed ID: 7052112 [No Abstract] [Full Text] [Related]
16. Sulfinpyrazone in the prevention of sudden death after myocardial infarction. Anturane Reinfarction Trial Research Group. N Engl J Med; 1980 Jan 31; 302(5):250-6. PubMed ID: 6985706 [Abstract] [Full Text] [Related]
17. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study). Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM. Am J Cardiol; 1989 Jun 15; 63(20):1518-20. PubMed ID: 2729140 [No Abstract] [Full Text] [Related]
18. Beta blocking agents: current status in the prevention of sudden coronary death. Hjalmarson A. Ann N Y Acad Sci; 1982 Jun 15; 382():305-23. PubMed ID: 6123286 [No Abstract] [Full Text] [Related]
19. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials. Schröder R. Z Kardiol; 1985 Jun 15; 74 Suppl 6():165-72. PubMed ID: 2869616 [Abstract] [Full Text] [Related]
20. The use of beta blockers for the reduction of mortality after myocardial infarction. Hampton JR. Eur Heart J; 1981 Aug 15; 2(4):259-68. PubMed ID: 6117465 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]